| 2026-02-03 | -16.5% | earnings | Seeking Alpha | Boston Scientific Q4 2025 Earnings Preview |
| 2026-02-04 | -13.5% | news | Seeking Alpha | Boston Scientific outlines 10% to 11% organic growth target for 2026 amid continued strength in EP and WATCHMAN |
| 2026-02-04 | -13.5% | earnings | Seeking Alpha | Boston Scientific Corporation (BSX) Q4 2025 Earnings Call Transcript |
| 2026-02-04 | -13.5% | earnings | Seeking Alpha | Boston Scientific slips despite Q4 beat as outlook trails consensus |
| 2026-02-04 | -13.5% | earnings | Seeking Alpha | Earnings Snapshot: Boston Scientific guides FY2026 net sales growth of ~10.5–11.5%, adjusted EPS of $3.43–$3.49 |
| 2026-02-04 | -13.5% | earnings | Seeking Alpha | Boston Scientific Non-GAAP EPS of $0.80 beats by $0.02, revenue of $5.29B beats by $10M |
| 2026-02-04 | -13.5% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-02-04 | -13.5% | earnings | Yahoo Finance | Boston Scientific shares slide on cautious 2026 revenue forecast - Yahoo Finance |
| 2026-02-04 | -13.5% | earnings | ChartMill | Boston Scientific Corp (NYSE:BSX) Stock Plummets 9% Despite Mixed Q4 2025 Earnings - ChartMill |
| 2026-03-30 | -11.8% | news | Seeking Alpha | Stocks to watch on Monday after market: VRDN, BSX, MTB, AL |
| 2026-03-30 | -11.8% | news | Seeking Alpha | Boston Scientific drops on data for Watchman device for stroke reduction |
| 2026-03-30 | -11.8% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2026-03-30 | -11.8% | news | Yahoo Finance | Boston Scientific (BSX) Stock Trades Down, Here Is Why - Yahoo Finance |
| 2026-03-30 | -11.8% | legal | Quiver Quantitative | Boston Scientific (BSX) slides as 2026 outlook and legal/regulatory overhang weigh on sentiment - Quiver Quantitative |
| 2026-04-22 | +9.7% | news | Seeking Alpha | Boston Scientific forecasts 2026 organic growth of 6.5% to 8% amid revised outlook for EP and WATCHMAN |
| 2026-04-22 | +9.7% | earnings | Seeking Alpha | Boston Scientific Corporation (BSX) Q1 2026 Earnings Call Transcript |
| 2026-04-22 | +9.7% | earnings | Seeking Alpha | Boston Scientific Corporation 2026 Q1 - Results - Earnings Call Presentation |
| 2026-04-22 | +9.7% | earnings | Seeking Alpha | Boston Scientific cuts full-year outlook despite Q1 beat |
| 2026-04-22 | +9.7% | earnings | Seeking Alpha | Boston Scientific Non-GAAP EPS of $0.80 beats by $0.01, revenue of $5.2B beats by $30M |
| 2026-04-22 | +9.7% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | +9.7% | news | PR Newswire | Boston Scientific announces results for first quarter 2026 - PR Newswire |
| 2026-04-22 | +9.7% | news | Reuters | Boston Scientific cuts annual forecast, shares rise on reset - Reuters |
| 2026-04-22 | +9.7% | news | ChartMill | BSX Stock Price, Quote & Chart | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill |
| 2026-04-22 | +9.7% | earnings | Seeking Alpha | Boston Scientific cuts full-year outlook despite Q1 beat (BSX:NYSE) - Seeking Alpha |
| 2026-04-22 | +9.7% | earnings | Investing.com | Earnings call transcript: Boston Scientific Q1 2026 sees mixed results, stock rises - Investing.com |
| 2026-04-22 | +9.7% | news | TIKR.com | Boston Scientific Stock: Is the EP Share Loss Fear Creating a 60% Mispricing Right Now? - TIKR.com |
| 2026-04-22 | +9.7% | earnings | StockStory | Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales - StockStory |
| 2026-04-22 | +9.7% | earnings | Seeking Alpha | Boston Scientific Corporation 2026 Q1 - Results - Earnings Call Presentation (NYSE:BSX) 2026-04-22 - Seeking Alpha |
| 2026-04-22 | +9.7% | earnings | MarketBeat | CPC Advisors LLC Sells 27,747 Shares of Boston Scientific Corporation $BSX - MarketBeat |
| 2026-04-22 | +9.7% | news | TipRanks | Here’s Why Boston Scientific Stock (BSX) Is Up 10% Today - TipRanks |
| 2026-04-22 | +9.7% | earnings | StocksToTrade | Boston Scientific Stock Sits At Crossroads As Traders Eye Earnings - StocksToTrade |
| 2026-04-22 | +9.7% | earnings | ChartMill | Boston Scientific Corp (NYSE:BSX) Reports Mixed Q1 2026 Results, Slight Revenue Miss Amid Profit Beat - ChartMill |
| 2026-04-22 | +9.7% | earnings | WKYC | Boston Scientific: Q1 Earnings Snapshot - WKYC |
| 2026-04-22 | +9.7% | earnings | MarketBeat | 2,652,522 Shares in Boston Scientific Corporation $BSX Bought by Alphinity Investment Management Pty Ltd - MarketBeat |
| 2026-04-22 | +9.7% | news | GuruFocus | Boston Scientific (BSX) Sees Significant Morning Gains - GuruFocus |
| 2026-04-22 | +9.7% | earnings | MarketBeat | Boston Scientific (NYSE:BSX) Issues Earnings Results - MarketBeat |
| 2026-04-22 | +9.7% | legal | StocksToTrade | Boston Scientific BSX Draws Bullish Targets Despite Lawsuit Hit - StocksToTrade |
| 2026-04-22 | +9.7% | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Grows Stake in Boston Scientific Corporation $BSX - MarketBeat |
| 2026-04-22 | +9.7% | news | TradingKey | Boston Scientific Corp Stock (BSX) Moved Up by 9.21% on Apr 22: What Investors Need To Know - TradingKey |
| 2026-04-22 | +9.7% | earnings | GuruFocus | Boston Scientific (BSX) Lowers Full-Year Outlook Despite Q1 Earnings Beat - GuruFocus |
| 2026-04-22 | +9.7% | earnings | TradingView | BSX Q1 Earnings Match, '26 View Down, Stock Gains in Premarket - TradingView |
| 2026-04-22 | +9.7% | news | GuruFocus | A Look at Boston Scientific Corp (BSX) After 9.0% Gain -- GF Val - GuruFocus |
| 2026-04-22 | +9.7% | earnings | MarketBeat | Boston Scientific (NYSE:BSX) Updates FY 2026 Earnings Guidance - MarketBeat |
| 2026-04-22 | +9.7% | earnings | MarketBeat | Boston Scientific (NYSE:BSX) Issues Q2 2026 Earnings Guidance - MarketBeat |
| 2026-04-22 | +9.7% | earnings | GuruFocus | Boston Scientific (BSX) Reports Q1 Earnings with Revenue Growth and EPS Beat - GuruFocus |
| 2026-04-22 | +9.7% | earnings | marketscreener.com | Boston Scientific Corporation Provides Earnings Guidance for the Second Quarter and Full Year 2026 - marketscreener.com |
| 2026-03-29 | -8.7% | news | Seeking Alpha | Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo - Slideshow |
| 2026-03-29 | -8.7% | news | Seeking Alpha | Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript |
| 2024-04-24 | +6.6% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-04-20 | -6.5% | news | Yahoo Finance | Truist Cuts PT on Boston Scientific Corporation (BSX) to $90 From $92 - Yahoo Finance |
| 2026-04-20 | -6.5% | legal | ChartMill | BSX Deadline: BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill |
| 2026-04-20 | -6.5% | legal | TMX Newsfile | BSX INVESTOR DEADLINE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - TMX Newsfile |
| 2026-04-20 | -6.5% | news | GuruFocus | A Look at Boston Scientific Corp (BSX) After 5.0% Decline -- GF Value $104.44 vs Price $60.99 - GuruFocus |
| 2026-04-20 | -6.5% | news | Business Wire | Robbins LLP Encourages BSX Stockholders to Contact the Firm for Information About the Class Action Against Boston Scientific - Business Wire |
| 2026-04-20 | -6.5% | news | TradingKey | Boston Scientific Corp Stock (BSX) Closed Down by 5.05% on Apr 20: What Signal Does It Send? - TradingKey |
| 2026-04-20 | -6.5% | earnings | MarketBeat | Krilogy Financial LLC Acquires New Holdings in Boston Scientific Corporation $BSX - MarketBeat |
| 2026-04-20 | -6.5% | news | DirectorsTalk Interviews | Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 50% Potential Upside for Investors - DirectorsTalk Interviews |
| 2026-01-15 | -6.2% | news | Seeking Alpha | Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision |
| 2026-01-15 | -6.2% | M&A | Seeking Alpha | Boston Scientific Acquiring Penumbra Was The Logical Next Step |
| 2026-01-15 | -6.2% | news | Seeking Alpha | Boston Scientific Corporation (BSX) M&A Call Transcript |
| 2026-01-15 | -6.2% | news | Seeking Alpha | Boston Scientific Corporation (BSX) Penumbra, Inc. - M&A Call - Slideshow |
| 2026-01-15 | -6.2% | legal | SEC EDGAR | BSX 8-K: 1.01 and (SEC Filing) |
| 2026-01-15 | -6.2% | news | Yahoo Finance | Why Boston Scientific (BSX) Stock Is Down Today - Yahoo Finance |
| 2026-04-21 | +6.0% | earnings | Seeking Alpha | Boston Scientific Q1 2026 Earnings Preview |
| 2026-04-21 | +6.0% | earnings | MarketBeat | Boston Scientific Corporation $BSX Stock Holdings Raised by TD Waterhouse Canada Inc. - MarketBeat |
| 2026-04-21 | +6.0% | earnings | MEXC | Boston Scientific (BSX) Stock Drops 36% as Analysts Revise Targets Ahead of Earnings - MEXC |
| 2026-04-21 | +6.0% | earnings | TradingView | Boston Scientific (BSX) Q1 Earnings: What To Expect - TradingView |
| 2026-04-21 | +6.0% | earnings | MarketBeat | Boston Scientific Target of Unusually High Options Trading (NYSE:BSX) - MarketBeat |
| 2026-04-21 | +6.0% | earnings | MarketBeat | Boston Scientific (NYSE:BSX) Price Target Lowered to $85.00 at Stifel Nicolaus - MarketBeat |
| 2026-04-21 | +6.0% | news | marketscreener.com | BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - marketscreener.com |
| 2024-01-31 | +5.9% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2024-01-31 | +5.9% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +5.6% | legal | SEC EDGAR | BSX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2026-02-26 | +5.6% | news | Yahoo Finance | Boston Scientific Corporation (BSX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance |
| 2026-02-26 | +5.6% | news | Yahoo Finance | What Does the Street Think About Boston Scientific Corporation (BSX)? - Yahoo Finance |
| 2026-01-19 | +5.6% | earnings | Seeking Alpha | ClearBridge Appreciation Strategy adds LHX, BSX, and ASMIY; exits CP, LEN, and TXN among Q4 moves |
| 2026-01-17 | +5.6% | M&A | Seeking Alpha | Key deals this week: Micron Technology, Worthington Steel, Boston Scientific, CrowdStrike and more |
| 2026-03-31 | -5.2% | analyst | TIKR.com | Boston Scientific Stock Tumbles 9% Following Raymond James Downgrade - TIKR.com |
| 2022-05-06 | -5.1% | legal | SEC EDGAR | BSX 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-03-03 | -5.1% | news | Seeking Alpha | Boston Scientific Corporation (BSX) Presents at TD Cowen 46th Annual Health Care Conference Transcript |
| 2026-04-19 | -4.8% | news | Yahoo Finance | Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now - Yahoo Finance |
| 2026-04-18 | -4.8% | news | ChartMill | Boston Scientific Corp (NYSE:BSX) Presents a Compelling Growth and Technical Setup Case - ChartMill |
| 2026-04-18 | -4.8% | earnings | MarketBeat | Asset Management One Co. Ltd. Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat |
| 2026-04-18 | -4.8% | earnings | MarketBeat | Boston Scientific Corporation $BSX Position Lifted by Ninety One UK Ltd - MarketBeat |
| 2026-04-18 | -4.8% | earnings | MarketBeat | Ninety One North America Inc. Acquires Shares of 77,718 Boston Scientific Corporation $BSX - MarketBeat |
| 2026-04-17 | -4.8% | earnings | Yahoo Finance | Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings - Yahoo Finance |
| 2026-04-23 | -4.7% | earnings | 24/7 Wall St. | Boston Scientific Just Slashed Guidance and Wall Street Followed. Is the Pullback a Buying Opportunity? |
| 2026-04-23 | -4.7% | earnings | MT Newswires | Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says |
| 2026-04-23 | -4.7% | earnings | Trefis | Why BSX Stock's Q1 Beat Is A Lagging Indicator |
| 2026-04-23 | -4.7% | earnings | StockStory | BSX Q1 Deep Dive: Market Outperformance Despite Lowered Guidance and Product-Specific Headwinds |
| 2026-04-23 | -4.7% | analyst | MT Newswires | Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating |
| 2026-04-23 | -4.7% | earnings | 24/7 Wall St. | Boston Scientific Just Slashed Guidance and Wall Street Followed. Is the Pullback a Buying Opportunity? - 24/7 Wall St. |
| 2026-04-23 | -4.7% | earnings | Benzinga | Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings - Benzinga |
| 2026-04-23 | -4.7% | news | GlobeNewswire | SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a - GlobeNewswire |
| 2022-07-27 | +4.5% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-03-25 | +4.2% | analyst | Seeking Alpha | Boston Scientific: Under Pressure, But Could See A Shift In Fortunes (Rating Upgrade) |
| 2024-11-15 | +4.1% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2025-10-23 | -4.1% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2021-07-27 | +3.8% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | -3.5% | news | Yahoo Finance | Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance |
| 2026-01-16 | +3.4% | news | Seeking Alpha | Boston Scientific: Adding Another Growth Engine With Penumbra |
| 2026-01-16 | +3.4% | news | Seeking Alpha | Boston Scientific's Bet On Penumbra Isn't To My Liking |
| 2026-01-16 | +3.4% | news | Yahoo Finance | This is Why Wall Street Firms are Bullish on Boston Scientific Corporation (BSX) - Yahoo Finance |
| 2021-04-28 | +3.4% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2024-07-30 | -3.4% | legal | SEC EDGAR | BSX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-02-07 | -3.3% | earnings | Yahoo Finance | Truist Cuts Boston Scientific Corporation (BSX) Price Target but Maintains Buy After Earnings Pullback - Yahoo Finance |
| 2026-03-17 | +3.3% | news | Yahoo Finance | Why Boston Scientific (BSX) Outpaced the Stock Market Today - Yahoo Finance |
| 2022-04-05 | +3.2% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2024-11-22 | -3.1% | legal | SEC EDGAR | BSX 8-K: 5.02 and (SEC Filing) |
| 2022-03-08 | -3.0% | legal | SEC EDGAR | BSX 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2021-10-27 | -3.0% | legal | SEC EDGAR | BSX 8-K: 2.02, 3.03 (SEC Filing) |
| 2024-07-24 | -2.7% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2025-04-23 | +2.7% | legal | SEC EDGAR | BSX 8-K: 5.02, 8.01 (SEC Filing) |
| 2025-04-23 | +2.7% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-04-07 | -2.6% | news | Yahoo Finance | Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance |
| 2026-04-07 | -2.6% | analyst | Yahoo Finance | Leerink Reiterates Outperform on Boston Scientific (BSX) After CHAMPION-AF Readout - Yahoo Finance |
| 2026-04-07 | -2.6% | news | Investing.com | Boston Scientific stock hits 52-week low at 61.23 USD - Investing.com |
| 2024-10-23 | -2.6% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2022-04-27 | -2.5% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2025-10-22 | +2.4% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2021-05-13 | -2.3% | legal | SEC EDGAR | BSX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2025-07-23 | +2.1% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2026-04-16 | -2.0% | analyst | Yahoo Finance | Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026 - Yahoo Finance |
| 2026-04-16 | -2.0% | earnings | MarketBeat | Boston Scientific Corporation $BSX Position Increased by KBC Group NV - MarketBeat |
| 2026-04-06 | -2.0% | analyst | Investing.com | Piper Sandler maintains Boston Scientific stock rating after device feedback - Investing.com |
| 2022-10-26 | +2.0% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2024-05-10 | -1.9% | legal | SEC EDGAR | BSX 8-K: 5.02, 5.03, 7.01, 8.01 (SEC Filing) |
| 2026-04-09 | -1.7% | news | Yahoo Finance | Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance |
| 2026-04-09 | -1.7% | legal | Yahoo Finance | Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System - Yahoo Finance |
| 2026-04-09 | -1.7% | news | GlobeNewswire | BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT - GlobeNewswire |
| 2022-02-15 | +1.7% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2023-07-27 | -1.7% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | +1.6% | legal | SEC EDGAR | BSX 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2025-11-19 | -1.5% | legal | SEC EDGAR | BSX 8-K: 5.02 and (SEC Filing) |
| 2021-10-06 | +1.5% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2026-02-20 | -1.5% | news | TIKR.com | Boston Scientific Stock is Down 20% This Year. Here Is What Investors Need to Know Before March 28 - TIKR.com |
| 2023-02-01 | +1.4% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2025-05-28 | -1.4% | legal | SEC EDGAR | BSX 8-K: 8.01 (SEC Filing) |
| 2026-03-04 | -1.3% | news | Yahoo Finance | Boston Scientific (BSX) Raises Share Buyback Authorization To $5B - Yahoo Finance |
| 2026-03-04 | -1.3% | news | Yahoo Finance | Is It Time To Reconsider Boston Scientific (BSX) After The Recent Share Price Pullback - Yahoo Finance |
| 2023-06-27 | -1.2% | legal | SEC EDGAR | BSX 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-06-06 | -1.2% | legal | SEC EDGAR | BSX 8-K: 8.01 (SEC Filing) |
| 2023-01-31 | +1.2% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2022-03-17 | -1.2% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2026-04-13 | +1.1% | earnings | Yahoo Finance | Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance |
| 2026-02-23 | +1.1% | legal | SEC EDGAR | BSX 8-K: 5.02, 7.01, 8.01 (SEC Filing) |
| 2026-02-23 | +1.1% | news | Yahoo Finance | Here is Why Boston Scientific Corporation (BSX) is Highly Favored by Hedge Funds - Yahoo Finance |
| 2026-03-06 | -1.0% | earnings | Yahoo Finance | Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - Yahoo Finance |
| 2025-01-16 | +1.0% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2021-11-09 | -0.9% | legal | SEC EDGAR | BSX 8-K: 8.01 (SEC Filing) |
| 2026-04-04 | -0.8% | earnings | Yahoo Finance | We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease - Yahoo Finance |
| 2025-09-04 | -0.8% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2024-04-04 | +0.8% | legal | SEC EDGAR | BSX 8-K: 8.01 (SEC Filing) |
| 2023-03-01 | +0.7% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2021-08-02 | -0.7% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2026-04-01 | -0.7% | news | Seeking Alpha | Sysco and Boston Scientific is the most oversold U.S. large-cap stock |
| 2026-04-01 | -0.7% | earnings | Seeking Alpha | Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags |
| 2026-04-01 | -0.7% | news | Seeking Alpha | Boston Scientific: From Hypergrowth To Durable Compounding |
| 2026-04-01 | -0.7% | news | Seeking Alpha | Sysco and Boston Scientific is the most oversold U.S. large-cap stock (DG:NYSE) - Seeking Alpha |
| 2023-10-26 | +0.7% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2025-02-05 | +0.7% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2021-09-21 | +0.7% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2022-02-02 | -0.6% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2025-12-22 | -0.6% | news | Yahoo Finance | Is Boston Scientific (BSX) One of the Best Healthcare AI Stocks to Buy Now? - Yahoo Finance |
| 2025-02-12 | -0.6% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2024-01-08 | +0.6% | legal | SEC EDGAR | BSX 8-K: 1.01 and (SEC Filing) |
| 2021-09-01 | -0.6% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2024-02-27 | +0.4% | legal | SEC EDGAR | BSX 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2025-11-20 | +0.4% | news | Yahoo Finance | Boston Scientific Corporation's (NYSE:BSX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance |
| 2021-11-23 | -0.4% | legal | SEC EDGAR | BSX 8-K: 5.02 and (SEC Filing) |
| 2026-04-02 | +0.4% | analyst | Investing.com | RBC Capital reiterates Boston Scientific stock rating on growth outlook - Investing.com |
| 2026-02-05 | +0.4% | earnings | Seeking Alpha | Boston Scientific Corporation 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-05 | +0.4% | legal | SEC EDGAR | BSX 8-K: 5.02 (SEC Filing) |
| 2022-11-21 | +0.4% | legal | SEC EDGAR | BSX 8-K: 5.02 and (SEC Filing) |
| 2026-04-14 | +0.2% | analyst | Yahoo Finance | Citi Reiterates Buy rating for Boston Scientific (BSX) - Yahoo Finance |
| 2026-04-14 | +0.2% | legal | Morningstar | BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm - Morningstar |
| 2023-04-26 | +0.2% | legal | SEC EDGAR | BSX 8-K: 2.02 and (SEC Filing) |
| 2021-06-24 | -0.2% | legal | SEC EDGAR | BSX 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-06-24 | -0.2% | legal | SEC EDGAR | BSX 8-K: 8.01 and (SEC Filing) |
| 2026-03-20 | +0.2% | news | Yahoo Finance | Jim Cramer on Boston Scientific: “This Stock Was One of the Greatest Performers, It’s Not Anymore” - Yahoo Finance |
| 2026-03-24 | +0.1% | news | Yahoo Finance | Is Boston Scientific Corporation (BSX) A Good Stock To Buy Now? - Yahoo Finance |
| 2026-03-24 | +0.1% | news | The Globe and Mail | Why Boston Scientific's Big Dip Could Be a Bigger Opportunity - The Globe and Mail |
| 2023-11-22 | +0.1% | legal | SEC EDGAR | BSX 8-K: 5.02 and (SEC Filing) |
| 2026-03-15 | -0.1% | news | Yahoo Finance | Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress? - Yahoo Finance |
| 2026-04-26 | — | news | PR Newswire | Data at Heart Rhythm 2026 highlight key Boston Scientific therapies |
| 2026-04-26 | — | earnings | Stock Titan | One Boston Scientific heart device beat drug therapy in new trial data - Stock Titan |
| 2026-04-26 | — | news | GuruFocus | Boston Scientific (BSX) Unveils Promising Results for Heart Tech - GuruFocus |
| 2026-04-25 | — | earnings | MarketBeat | Boston Scientific Corporation $BSX Shares Sold by China Universal Asset Management Co. Ltd. - MarketBeat |
| 2026-04-25 | — | legal | TMX Newsfile | BSX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX - TMX Newsfile |
| 2026-04-25 | — | earnings | MarketBeat | Calamos Wealth Management LLC Cuts Stake in Boston Scientific Corporation $BSX - MarketBeat |
| 2026-04-25 | — | news | GuruFocus | A Look at Boston Scientific Corp (BSX) After 5.5% Decline -- GF Value $104.55 vs Price $62.07 - GuruFocus |
| 2026-04-25 | — | legal | marketscreener.com | BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com |
| 2026-04-24 | — | earnings | Zacks | Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1? |
| 2026-04-24 | — | analyst | Simply Wall St. | How The Investment Story Is Resetting For Boston Scientific (BSX) After Recent Analyst Shifts |
| 2026-04-24 | — | news | StockStory | 1 Oversold Stock Set for a Comeback and 2 We Avoid |
| 2026-04-24 | — | earnings | MarketBeat | Boston Scientific Q1 Earnings Call Highlights |
| 2026-04-24 | — | news | GuruFocus | Boston Scientific Corp (BSX) Stock Price, Trades & News - GuruFocus |
| 2026-04-24 | — | earnings | TradingView | Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1? - TradingView |
| 2026-04-24 | — | analyst | The Globe and Mail | Analysts’ Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and Sanofi (OtherSNYNF) - The Globe and Mail |
| 2026-04-24 | — | news | GlobeNewswire | BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline - GlobeNewswire |
| 2026-04-24 | — | analyst | Yahoo Finance | How The Investment Story Is Resetting For Boston Scientific (BSX) After Recent Analyst Shifts - Yahoo Finance |
| 2026-04-24 | — | news | TradingKey | Boston Scientific Corp Stock (BSX) Closed Down by 5.56% on Apr 24: Drivers Behind the Movement - TradingKey |